Argentina approves Sputnik Light Covid-19 shot as standalone and booster
Sputnik Light showed effectiveness as a universal boost when mixed with the vaccines of AstraZeneca,...
News
Canada enters deals to procure Merck and Pfizer’s Covid-19 antiviral pills
Pfizer anticipates supplying one million courses of its investigational oral pill through next year.
COVID-19 health concern continues to decline in November: Poll
The health concern over COVID-19 declined for the third consecutive month in November, shows the...
FDA grants EUA to Lilly’s Covid-19 antibody therapy for paediatric use
The EUA has been granted based on safety and efficacy data from the BLAZE-1 trial...
Recordati to acquire EUSA Pharma to expand rare disease products portfolio
EUSA Pharma’s product portfolio includes Qarziba, Sylvant, Fotivda and Caphosol.
UCB and Novartis to co-develop two drug candidates for Parkinson’s Disease
UCB and Novartis will jointly fund and manage the future clinical development of the drugs.
UK’s MHRA grants authorisation for GSK-Vir Biotechnology’s Covid-19 drug
MHRA has recommended the use of GSK and Vir Biotechnology’s Xevudy within five days from the start of Covid-19 symptoms.
Astellas and Dyno Therapeutics to develop AAV gene therapy vectors
Dyno will design the new AAV capsids with improved functional properties for gene therapy.
Oravax Medical to test triple antigen oral vaccine against Omicron
The vaccine candidate is expected to be used as an independent vaccine or as a booster drug for people vaccinated earlier.
Italy approves Pfizer and BioNTech’s Covid-19 vaccine for children
The dosage for children is indicated to be a third of the authorised 30µg dose given to adults and adolescents.
RedHill Biopharma reports rise in Q3 2021 net revenues
Talicia reported a 15% increase in new prescriptions and a 117% rise compared to the third quarter of last year.
